Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Ultima Vez Modificado: 27 de junio del 2004
Dear OncoLink "Ask The Experts,"
I was first diagnosed with complex hyperplasia with atypical hyperplasia in the endometrium in June 2000. I was given Provera 30mg for 3 months. The biopsy results remained the same so I was subsequently given 100mg for another 3 months. Almost immediately at the end of the course, I managed to conceive without taking any fertility pills. The baby was delivered healthy at full term. However, in Dec 2003, I was diagnosed with complex atypical hyperplasia. I was advised to have a hysterectomy. My doctor said that I may have a genetic disorder & he believes that the imbalance of estrogen and progestrone may not cause the hyperplasia. I have read that some studies in Europe found that women with this problem can be cured by using the Mirena IUD tipped with progestrone. Please comment.
Christina S. Chu, MD, Assistant Professor of the Division of Gynecologic Oncology at the University of Pennsylvania Health System, responds:
Currently, the standard treatment recommendation for women with complex atypical hyperplasia of the endometrium involves removal of the uterus. Studies have demonstrated that about 15-20% of women with complex atypical hyperplasia found on endometrial biopsy may either have concurrent endometrial cancer in their uterus (not detected by the biopsy) or go on to develop endometrial cancer if left untreated.
A recent study performed in Norway used a progesterone IUD. The specific type of progesterone used was called levonorgestrel. (This IUD is marketed in the United States under the trade name "Mirena".) In this small study, only 7 women with complex atypical hyperplasia were treated, and after only three months of follow up, were shown to have normal endometrium at the time of a second endometrial biopsy or D&C. While these results sound promising, three months is a very short follow up, and 7 patients is a very small number. Larger studies will definitely be needed to investigate the effectiveness of this treatment strategy.
Given the lack of large studies demonstrating the effectiveness of the IUD as a treatment for complex atypical hyperplasia, once women have completed childbearing, I would advise strong consideration to removal of the uterus. Please discuss your concerns with your physician.
Endocrine System Cancers
Head and Neck Cancers
Urinary Tract Cancers
Bone Marrow Transplants
General Treatment Concerns
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
Cancer Resource List
Resources for Young Adults